TB-500 (TB5)

Healing Preclinical

Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026

TL;DR — TB-500 at a Glance

TB-500 (TB5) is a healing peptide, at the preclinical stage in the published literature. TB-500 is a synthetic version of the naturally occurring 43-amino acid peptide Thymosin Beta-4 (Tβ4). This peptide is found in virtually all human and animal cells and plays a fundamental role in building new blood vessels, new muscle tissue fibers, and promoting cell migration and differentiation. TB-500 is the primary regulator of actin, a cell-building protein essential for healing and cell migration. Its unique molecular structure allows it to travel long distances through tissues, which explains its systemic healing properties. The peptide has been extensively studied in animal models for wound healing, cardiac protection, and tissue regeneration applications. Unlike many peptides that act locally, TB-500 can affect tissues throughout the body due to its ability to regulate actin systemically, making it particularly interesting for research into whole-body healing responses.

TB-500 is a synthetic version of the naturally occurring 43-amino acid peptide Thymosin Beta-4 (Tβ4). This peptide is found in virtually all human and animal cells and plays a fundamental role in building new blood vessels, new muscle tissue fibers, and promoting cell migration and differentiation. TB-500 is the primary regulator of actin, a cell-building protein essential for healing and cell migration. Its unique molecular structure allows it to travel long distances through tissues, which explains its systemic healing properties. The peptide has been extensively studied in animal models for wound healing, cardiac protection, and tissue regeneration applications. Unlike many peptides that act locally, TB-500 can affect tissues throughout the body due to its ability to regulate actin systemically, making it particularly interesting for research into whole-body healing responses.

Key Data

Research StatusPreclinical
Half-Life2-3 days
AdministrationSubcutaneous injection
Doses Reported in Published Studies2-5 mg per week
Molecular Weight4,982 Da (full peptide) | Active fragment LKKTETQ: 846.97 g/mol
Molecular FormulaC212H350N56O78S (full) | Active fragment: C36H66N10O13

Mechanism of Action

Promotes cell migration and differentiation, upregulates actin, reduces inflammation through multiple pathways.

Reported Benefits

Frequently Asked Questions

What is TB-500?

TB-500 is a synthetic version of the naturally occurring 43-amino acid peptide Thymosin Beta-4 (Tβ4). This peptide is found in virtually all human and animal cells and plays a fundamental role in building new blood vessels, new muscle tissue fibers, and promoting cell migration and differentiation. TB-500 is the…

How does TB-500 work?

Promotes cell migration and differentiation, upregulates actin, reduces inflammation through multiple pathways.

What is the research status of TB-500?

TB-500 is at the following stage in the published literature: Preclinical. All information is for research and educational purposes only.

What is the half-life of TB-500?

Reported half-life: 2-3 days.

How is TB-500 administered in research?

Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.

Educational content, not medical advice. Effects described are drawn from cited research in study subjects.

← All Peptides Dosing Calculator The Dispatch Home